title: Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
abstract: Naturally acquired anti-Pseudomonas aeruginosa antibody fails to afford protection against repeated P. aeruginosa bronchopulmonary exacerbations in cystic fibrosis (CF) patients. In an effort to explain this phenomenon, the titer and affinity constants of serum anti-lipopolysaccharide (LPS) IgG were determined in five study groups: healthy adults before and after immunization with a polyvalent LPS-based vaccine, healthy noncolonized CF patients before and after immunization, nonimmunized CF patients with significantly elevated anti-LPS antibody titers without documented colonization, recently colonized CF patients before and after immunization, and nonimmunized CF patients chronically colonized with P. aeruginosa. Immunization elicited a significant rise in total anti-LPS immunoglobulin levels and affinity constants in both healthy adults and CF patients. Although chronically colonized patients had elevated levels of total anti-LPS antibody, these antibodies possessed affinities at least 100-fold less than those of vaccine-induced antibodies.
authors.affiliation: Swiss Serum and Vaccine Institute, Inselspital, University of Berne, Switzerland.
authors.forename: U
authors.initials: U
authors.lastname: Bruderer
authors.forename: S J
authors.initials: SJ
authors.lastname: Cryz
authors.forename: U B
authors.initials: UB
authors.lastname: Schaad
authors.forename: M
authors.initials: M
authors.lastname: Deusinger
authors.forename: J U
authors.initials: JU
authors.lastname: Que
authors.forename: A B
authors.initials: AB
authors.lastname: Lang
mesh_terms: D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood*; D000915:Antibody Affinity; D001428:Bacterial Vaccines / Q000276:immunology*; D003550:Cystic Fibrosis / Q000150:complications / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007114:Immunization; D007117:Immunization, Secondary; D007074:Immunoglobulin G / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000276:immunology*; D009895:Opsonin Proteins / Q000276:immunology; D010587:Phagocytosis; D011552:Pseudomonas Infections / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D009895:Opsonin Proteins